Adjuvant Development in the context of vaccines for Zika, Dengue and West Nile virus
Adjuvant Development in the context of vaccines for Zika, Dengue and West Nile virus
批准号:
10643693
负责人:
SUNIL DAVID
金额:
$198.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2023-09-29
中文摘要
该合同支持通过免疫学表征研究和化合物优化开发佐剂,包括IND使能研究。主要重点将是测试和进一步开发用于人类许可的佐剂,作为许可或研究疫苗的组成部分,以防止一种或多种与人类疾病相关的非HIV疾病病原体。
英文摘要
This contract supports the development of an adjuvant through immunological characterization studies and compound optimization, up to and including IND-enabling studies. The main emphasis will be on testing and further development of the adjuvant for human licensure as a component of a licensed or investigational vaccine to protect against one or more non-HIV disease pathogens relevant to human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADJUVANT DEVELOPMENT PROGRAM - COVID-19 Supplement
-
批准号:10285318
-
项目类别:
-
资助金额:$65.0万
-
财政年份:2018
-
负责人:SUNIL DAVID
-
依托单位:
Develop a candidate subunit vaccine for Powassan Virus and West Nile virus adjuvanted with Alhydroxiquim-II
-
批准号:10678270
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2018
-
负责人:SUNIL DAVID
-
依托单位:
Adjuvant discovery: Zika
-
批准号:9543914
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:SUNIL DAVID
-
依托单位:
Adjuvant Discovery For Diphtheria Toxin Vaccine
-
批准号:8936750
-
项目类别:
-
资助金额:$835.33万
-
财政年份:2014
-
负责人:SUNIL DAVID
-
依托单位:
Novel adjuvants acting through TLR2, TLR5 and TLR7 receptors
-
批准号:8326029
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2009
-
负责人:SUNIL DAVID
-
依托单位:
Novel adjuvants acting through TLR2, TLR5 and TLR7 receptors
-
批准号:8751015
-
项目类别:
-
资助金额:$134.45万
-
财政年份:2009
-
负责人:SUNIL DAVID
-
依托单位:
Novel adjuvants acting through TLR2, TLR5 and TLR7 receptors
-
批准号:7950544
-
项目类别:
-
资助金额:$550.6万
-
财政年份:2009
-
负责人:SUNIL DAVID
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: